GENEVA, Feb. 7 -- HANGZHOU QIANDAI BIOTECHNOLOGY CO., LTD. (Room 904-5, Building 1, Chuanhua Science And Technology Innovation Building, Ningwei Street, Xiaoshan DistrictHangzhou, Zhejiang 311000), 杭州仟岱生物科技有限公司 (中国浙江省杭州市萧山区宁围街道传化科创大厦1幢904室-5) filed a patent application (PCT/CN2024/113022) for "IMMUNOGENIC MYCOPLASMA PNEUMONIAE POLYPEPTIDE EPITOPE AND RECOMBINANT PROTEIN CONTAINING SAME, AND MYCOPLASMA PNEUMONIA VACCINE" on Aug 19, 2024. With publication no. WO/2026/025554, the details related to the ...